Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection

J Chin Med Assoc. 2011 Mar;74(3):130-3. doi: 10.1016/j.jcma.2011.01.028. Epub 2011 Feb 22.

Abstract

The worldwide outbreak of pandemic influenza A (H1N1 influenza) infection in 2009 caused numerous hospitalizations and deaths resulting from severe complications such as pneumonia, sepsis, and acute respiratory distress syndrome. Fulminant myocarditis caused by H1N1 infection has been reported in children but rarely in adults. We present an adult who contracted H1N1 infection followed by fulminant myocarditis. Early implementation of extra-corporeal membrane oxygenation support in conjunction with a specific anti-influenza viral medication (Oseltamivir) led to the patient's complete recovery from cardiogenic shock in 2 weeks.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Extracorporeal Membrane Oxygenation
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / complications*
  • Influenza, Human / drug therapy
  • Male
  • Myocarditis / etiology*
  • Myocarditis / therapy
  • Oseltamivir / therapeutic use
  • Pandemics*

Substances

  • Oseltamivir